Advances in Clinical Genomics Profiling
Local Cancer Genomic Profiling Options Grow, Though Central Labs Will Likely Keep Major Role
Premium
As economic and practical challenges of next-gen sequencing have eased in recent years, more groups are bringing comprehensive cancer genomic testing in house.
Postsurgical ctDNA Analysis Predicts Adjuvant Chemotherapy Benefit in NSCLC
Research out of Geneseeq and the Chinese Academy of Medical Sciences shows the value of ctDNA analysis to guide treatment and predict disease recurrence.
Cancer Genomic Analysis Reveals Distinct Features in Tumors From Patients Under 50 Years Old
Researchers saw distinct driver mutation, tumor microenvironment features, and more when they compared tumors from dozens of cancer types in patients younger or older than 50.
The technique, used in noninvasive prenatal testing to detect microduplications or microdeletions, could detect copy number alterations in B-cell lymphoma patients.
Analysis Finds Sibling Cascade Testing Could Be Cost Effective in Pediatric Cancer
The analysis also found that about half the sibling deaths due to cancer could be averted by surveillance following cascade testing, as compared to usual care.